Pharsight to Work with Critical Path Institute’s Polycystic Kidney Disease Consortium on Disease Progression Modeling Pharsight, a market-leading provider of software and scientific consulting services to improve productivity and decisionmaking in
Critical Path Institute’s Predictive Safety Testing Consortium Announces Special Issue of Nature Biotechnology Dedicated to Newly Qualified Kidney Safety Biomarkers A special May 10, 2010 issue of Nature Biotechnology (NBT) includes ten scientific publications from Critical Path Institute’
